Protective action of resveratrol in human skin: Possible involvement of specific receptor binding sites

PLoS ONE

Volumn 5, Issue 9, 2010, Pages

  Bastianetto, Stéphane ^a   Dumont, Yvan ^a   Duranton, Albert ^b   Vercauteren, Freya ^a   Breton, Lionel ^b   Quirion, Rémi ^a  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b L ORÉAL RECHERCHE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIGALLOCATECHIN GALLATE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PICEATANNOL; RESVERATROL; CELL SURFACE RECEPTOR; FLAVONOID; NITRIC OXIDE DONOR; PHENOL DERIVATIVE; POLYPHENOLS; PROTECTIVE AGENT; STILBENE DERIVATIVE;

ADULT; AGED; AGING; APOPTOSIS; ARTICLE; CELL DEATH; CELL IMMORTALIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG EXPOSURE; DRUG MECHANISM; DRUG RECEPTOR BINDING; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MITOCHONDRIAL RESPIRATION; SKIN DISEASE; SKIN PROTECTION; CELL CULTURE; CELL MEMBRANE; CYTOLOGY; DRUG EFFECT; FEMALE; METABOLISM; MIDDLE AGED; PROTEIN BINDING; SKIN; TUMOR CELL LINE;

AGED; APOPTOSIS; CELL LINE, TUMOR; CELL MEMBRANE; CELLS, CULTURED; FEMALE; FLAVONOIDS; HUMANS; MIDDLE AGED; NITRIC OXIDE DONORS; PHENOLS; PROTECTIVE AGENTS; PROTEIN BINDING; RECEPTORS, CELL SURFACE; SKIN; STILBENES;

EID: 77958531915     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012935     Document Type: Article

References (41)

1. Renaud SC, Gueguen R, Conard P, Lanzmann-Petithory D, Orgogozo JM, et al. (2004) Moderate wine drinkers have lower hypertension-related mortality: a prospective cohort study in French men. Am J Clin Nutr 80: 621-625.
2. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM (1995) The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 235: 207-219.
3. La VC (2009) Association between Mediterranean dietary patterns and cancer risk. Nutr Rev 67 Suppl 1: S126-S129.
4. Feart C, Samieri C, Rondeau V, Amieva H, Portet F, et al. (2009) Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA 302: 638-648.
5. Goldberg DM, Hahn SE, Parkes JG (1995) Beyond alcohol: beverage consumption and cardiovascular mortality. Clin Chim Acta 237: 155-187.
6. Anekonda TS (2006) Resveratrol-a boon for treating Alzheimer's disease? Brain Res Rev 52: 316-326.
7. Chan MM (2002) Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin. Biochem Pharmacol 63: 99-104.
8. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, et al. (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24: 2783-2840.
9. Liu RH (2003) Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr 78: 517S-520S.
10. Corder R, Douthwaite JA, Lees DM, Khan NQ, Viseu Dos Santos AC, et al. (2001) Endothelin-1 synthesis reduced by red wine. Nature 414: 863-864.
11. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE (1993) Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341: 454-457.
12. Marambaud P, Zhao H, Davies P (2005) Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 280: 37377-37382.
13. Han YS, Zheng WH, Bastianetto S, Chabot JG, Quirion R (2004) Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol 141: 997-1005.
14. Gan L, Han Y, Bastianetto S, Dumont Y, Unterman TG, et al. (2005) FoxOdependent and -independent mechanisms mediate SirT1 effects on IGFBP-1 gene expression. Biochem Biophys Res Commun 337: 1092-1096.
15. Dasgupta B, Milbrandt J (2007) Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci U S A 104: 7217-7222.
16. Bastianetto S, Zheng WH, Quirion R (2000) Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol 131: 711-720.
17. Bastianetto S (2002) Red wine consumption and brain aging. Nutrition 18: 432-433.
18. Bastianetto S, Quirion R (2004) Natural antioxidants and neurodegenerative diseases. Front Biosci 9: 3447-3452.
19. Bastianetto S, Krantic S, Quirion R (2008) Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease. Mini Rev Med Chem 8: 429-435.
20. Karuppagounder SS, Pinto JT, Xu H, Chen HL, Beal MF, et al. (2009) Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem Int 54: 111-118.
21. Han YS, Bastianetto S, Dumont Y, Quirion R (2006) Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain. J Pharmacol Exp Ther 318: 238-245.
22. Baxter RA (2008) Anti-aging properties of resveratrol: review and report of a potent new antioxidant skin care formulation. J Cosmet Dermatol 7: 2-7.
23. Orallo F (2008) Trans-resveratrol: a magical elixir of eternal youth? Curr Med Chem 15: 1887-1898.
24. Marques FZ, Markus MA, Morris BJ (2009) Resveratrol: Cellular actions of a potent natural chemical that confers a diversity of health benefits. Int J Biochem Cell Biol 41: 2125-2128.
25. Weller R (2003) Nitric oxide: a key mediator in cutaneous physiology. Clin Exp Dermatol 28: 511-514. 1365.
26. Baumann L (2007) Skin ageing and its treatment. J Pathol 211: 241-251. 10.1002/path.2098 [doi].
27. Villiotou V, Deliconstantinos G (1995) Nitric oxide, peroxynitrite and nitrosocompounds formation by ultraviolet A (UVA) irradiated human squamous cell carcinoma: potential role of nitric oxide in cancer prognosis. Anticancer Res 15: 931-942.
28. Deliconstantinos G, Villiotou V, Stravrides JC (1995) Release by ultraviolet B (u.v.B) radiation of nitric oxide (NO) from human keratinocytes: a potential role for nitric oxide in erythema production. Br J Pharmacol 114: 1257-1265.
29. Lee SK, Park DY, Lee HJ, Lee J, Choi MK, et al. (2007) Functional interaction between nitric oxide-induced iron homeostasis and heme oxygenase-1 in immortalized and malignant oral keratinocytes. Cancer Lett 249: 283-293.
30. Chen M, Sun HY, Li SJ, Das M, Kong JM, et al. (2009) Nitric oxide as an upstream signal of p38 mediates hypoxia/reoxygenation-induced neuronal death. Neurosignals 17: 162-168.
31. Jung JY, Han CR, Jeong YJ, Kim HJ, Lim HS, et al. (2007) Epigallocatechin gallate inhibits nitric oxide-induced apoptosis in rat PC12 cells. Neurosci Lett 411: 222-227.
32. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL (1996) Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A 93: 6770-6774.
33. Yu W, Fu YC, Zhou XH, Chen CJ, Wang X, et al. (2009) Effects of resveratrol on H(2)O(2)-induced apoptosis and expression of SIRTs in H9c2 cells. J Cell Biochem 107: 741-747.
34. Bournival J, Quessy P, Martinoli MG (2009) Protective Effects of Resveratrol and Quercetin Against MPP(+) -Induced Oxidative Stress Act by Modulating Markers of Apoptotic Death in Dopaminergic Neurons. Cell Mol Neurobiol 29: 1169-1180.
35. Lee ER, Kang YJ, Kim JH, Lee HT, Cho SG (2005) Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J Biol Chem 280: 31498-31507.
36. Bikle DD, Ng D, Tu CL, Oda Y, Xie Z (2001) Calcium- and vitamin Dregulated keratinocyte differentiation. Mol Cell Endocrinol 177: 161-171.
37. Salvolini E, Lucarini G, Zizzi A, Orciani M, Di BG, et al. (2010) Human skinderived mesenchymal stem cells as a source of VEGF and nitric oxide. Arch Dermatol Res 302: 367-374.
38. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, et al. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771.
39. Bozyczko-Coyne D, McKenna BW, Connors TJ, Neff NT (1993) A rapid fluorometric assay to measure neuronal survival in vitro. J Neurosci Methods 50: 205-216.
40. Sparrow RL, Tippett E (2005) Discrimination of live and early apoptotic mononuclear cells by the fluorescent SYTO 16 vital dye. J Immunol Methods 305: 173-187.
41. Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, et al. (1991) Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci U S A 88: 3671-3675.